Produktname:5,7-dichloro-8-fluoro-2-(methylsulfanyl)-3H,4H-pyrido[4,3-d]pyrimidin-4-one
IUPAC Name:5,7-dichloro-8-fluoro-2-(methylsulfanyl)-3H,4H-pyrido[4,3-d]pyrimidin-4-one
- CAS:2763157-90-8
- Molekulare Formel:C8H4Cl2FN3OS
- Reinheit:95%+
- Katalognummer:CM1043992
- Molekulargewicht:280.1
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:2763157-90-8
- Molekulare Formel:C8H4Cl2FN3OS
- Schmelzpunkt:-
- SMILES-Code:CSC1=NC2=C(C(=O)N1)C(=NC(=C2F)Cl)Cl
- Dichte:
- Katalognummer:CM1043992
- Molekulargewicht:280.1
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Column Infos
- HRS-4642
- HRS-4642 is a high affinity, selective, long-acting, and non-covalent KRAS G12D inhibitor, with an affinity constant of 0.083 nM. HRS-4642 demonstrated robust efficacy against KRAS G12D-mutant cancers both in vitro and in vivo. Importantly, in a phase 1 clinical trial, HRS-4642 exhibited promising anti-tumor activity in the escalating dosing cohorts. Furthermore, the sensitization and resistance spectrum for HRS-4642 was deciphered through genome-wide CRISPR-Cas9 screening, which unveiled proteasome as a sensitization target. HRS-4642, either as a single agent or in combination with carfilzomib, reshaped the tumor microenvironment toward an immune-permissive one.